Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Top Ranked Income Stocks To Buy For December 15th

Published 12/14/2017, 08:51 PM
Updated 07/09/2023, 06:31 AM

Here are four stocks with buy rank and strong income characteristics for investors to consider today, December 15th:

Horace Mann Educators Corporation (HMN): This multiline insurance company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 36% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.51%, compared with the industry average of 1.72%. Its five-year average dividend yield is 2.96%.

BCB Bancorp, Inc. (BCBP): This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.8% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 3.84%, compared with the industry average of 1.41%. Its five-year average dividend yield is 4.56%.

Prudential Financial (NYSE:PRU), Inc (PRU): This insurance company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 3.2% over the last 60 days.

Prudential (LON:PRU) Financial, Inc. Price and Consensus

Prudential Financial, Inc. price-consensus-chart | Prudential Financial, Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 2.63%, compared with the industry average of 1.72%. Its five-year average dividend yield is 2.83%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Citizens Financial Services, Inc. (CZFS): This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 2.73%, compared with the industry average of 1.41%. Its five-year average dividend yield is 3.09%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



Prudential Financial, Inc. (PRU): Free Stock Analysis Report

Horace Mann Educators Corporation (HMN): Free Stock Analysis Report

Citizens Financial Services Inc. (CZFS): Free Stock Analysis Report

BCB Bancorp, Inc. (NJ) (BCBP): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.